Literature DB >> 1749390

A rapid Candida albicans hyphal-form growth inhibition assay: determination of myelomonocytic-mediated antifungal activity.

L Scaringi1, E Blasi, P Cornacchione, C Bietta, F Bistoni.   

Abstract

An in vitro microassay for the measurement of Candida albicans hyphal-form growth inhibition by myelomonocytic cells is described. The assay is rapid, easy-to-perform and objective. A Candida strain capable of in vitro dimorphic transition from yeast to hyphal form has been employed. The assay is based on the incorporation of 3H-glucose by the fungus, the effect being dependent upon the time of pulse, size of the inoculum and concentration of radiolabelled metabolite. In particular, C. albicans hyphal form, obtained by a 3 h incubation in vitro in the presence of 10% fetal calf serum, is co-incubated with the effector cells. A pulse with 3H-glucose in water is then performed and the radioactivity incorporated by the residual Candida is taken as an indication of hyphal growth. We found that polymorphonuclear cells, peritoneal macrophages and the cloned GG2EE macrophage cell line significantly inhibited hyphal growth, the effects being time and effector-to-target cell ratio dependent.

Entities:  

Mesh:

Year:  1991        PMID: 1749390     DOI: 10.1111/j.1439-0507.1991.tb00631.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  6 in total

1.  Candida albicans killing by RAW 264.7 mouse macrophage cells: effects of Candida genotype, infection ratios, and gamma interferon treatment.

Authors:  A Marcil; D Harcus; D Y Thomas; M Whiteway
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

2.  Early differential molecular response of a macrophage cell line to yeast and hyphal forms of Candida albicans.

Authors:  E Blasi; L Pitzurra; M Puliti; L Lanfrancone; F Bistoni
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

3.  Influence of the Bcg locus on macrophage response to the dimorphic fungus Candida albicans.

Authors:  M Puliti; D Radzioch; R Mazzolla; R Barluzzi; F Bistoni; E Blasi
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

4.  Differential susceptibility of yeast and hyphal forms of Candida albicans to proteolytic activity of macrophages.

Authors:  E Blasi; L Pitzurra; A R Chimienti; R Mazzolla; M Puliti; R Barluzzi; F Bistoni
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

5.  Differential susceptibility of yeast and hyphal forms of Candida albicans to macrophage-derived nitrogen-containing compounds.

Authors:  E Blasi; L Pitzurra; M Puliti; A R Chimienti; R Mazzolla; R Barluzzi; F Bistoni
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

6.  Tumor necrosis factor as an autocrine and paracrine signal controlling the macrophage secretory response to Candida albicans.

Authors:  E Blasi; L Pitzurra; A Bartoli; M Puliti; F Bistoni
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.